A5016660013- Pediatric Hepatobiliary Diseases and Treatments
- Brain Metastases and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer and Skin Lesions
- Tumors and Oncological Cases
- Lung Cancer Treatments and Mutations
- Nonmelanoma Skin Cancer Studies
- Glioma Diagnosis and Treatment
- Esophageal and GI Pathology
- Gastrointestinal Tumor Research and Treatment
- Parathyroid Disorders and Treatments
- Cutaneous Melanoma Detection and Management
- Lipoproteins and Cardiovascular Health
- Case Reports on Hematomas
- Management of metastatic bone disease
- COVID-19 Impact on Reproduction
- Clinical Nutrition and Gastroenterology
- Multiple and Secondary Primary Cancers
- Gastric Cancer Management and Outcomes
- Intestinal and Peritoneal Adhesions
- Abdominal vascular conditions and treatments
- Advanced Radiotherapy Techniques
- Spondyloarthritis Studies and Treatments
Bridgeport Hospital
2023-2024
Yale University
2023
Lenox Hill Hospital
2018-2020
Columbia University Irving Medical Center
2016-2019
Northwell Health
2018
Aim: The number of breast cancer brain metastases is a prognostic clinical variable in the modified graded assessment (GPA) Index for cancer. Patients & methods: We retrospectively gathered data from 127 patients who underwent radiation therapy metastasis. were stratified by both GPA and scores, survival was determined using Kaplan–Meier curves Cox proportional hazards model. Results Conclusion: curve under classification not significant, but significant classification. inclusion into index...
ABSTRACT Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of several malignancies and may target cytotoxic T-lymphocyte-associated antigen-4, programmed cell death-1, death ligand 1, which work on maintaining peripheral immune tolerance. ICIs inhibit these ligands causing an immune-enhancing effect, leading to a wide spectrum complications from mild mucositis life-threatening pneumonitis or hepatitis. These are collectively called immune-related adverse...
Introduction: Primary Budd-Chiari syndrome (BCS) is a rare disease characterized by hepatic venous obstruction resulting from thrombosis and often associated with other syndromes hypercoagulability. Approximately 20% of cases are deemed idiopathic after extensive evaluation for prothrombotic disease. Here we present challenging case BCS refractory to apixaban. Case Description/Methods: A 35-year-old history myocarditis presents 1 week abdominal pain. Vitals were stable. Labs notable total...
INTRODUCTION: Colon cancer is the third most common type of globally and approximately 20% patients diagnosed with colon will already have metastatic disease at time diagnosis. The liver site metastasis, followed by lung, nervous system bones. Only 15% stage IV metastases to locations outside these sites. Here we report a rare presentation skeletal muscle (SM) metastases. CASE DESCRIPTION/METHODS: 81-year-old male peripheral artery diabetes mellitus presented severe right shoulder pain...
INTRODUCTION: The incidence of CRC continues to increase at a rate 2.1% per year in both men and women. Screening for improves prognosis by identifying early-stages treatment, resulting lower mortality. Compliance rates screening have been low, optimized clinical settings, range from 50% 70%. Fecal Immunochemical Test (FIT) has advantages over colonoscopy as it does not require bowel preparation anesthesia, is an easier test complete. We hypothesize that our academic community...